Rapid growth across Western Europe

Following the launch of ethoss in 2015, the company has achieved rapid growth in the UK and internationally – with deals signed with partners in Ireland, Italy, Netherlands, Belgium and France in recent weeks. 

Ethoss is an innovative synthetic bone graft solution for dental implants. The unique composition of ethoss, which has a built-in cell-occlusive barrier, removing the need for a separate collagen membrane, provides a highly stable graft and typically produces 50 per cent new bone after 12 weeks.  

Ethoss is a bi-phasic synthetic material made from a mixture of beta tri calcium phosphate and calcium sulfate and is completely free from animal or human content.  

The built-in membrane function prevents soft tissue ingress and helps to dramatically speed up healing times, by allowing the periosteum (and the related blood supply) direct contact with the graft site.  

This means surgical procedures can be completed much more quickly and reliably, benefitting both patient and dentist. 

The company had already established a foothold in the German and Greek markets and is seeing growth in both countries.